| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.17 | 0.0006 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0008 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.48 | 0.003 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | -0.097 | 0.003 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.44 | 0.005 |
| mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | 0.096 | 0.006 |
| mRNA | JW-7-24-1 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.007 |
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.008 |